🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#SYNTHIA PARTNER SPOTLIGHT: Michel Van Speybroeck, Janssen, highlights SYNTHIA’s role in advancing responsible, privacy-preserving healthcare research across Europe. #SYNTHIA #SyntheticData #PrivacyPreserving #DataInfrastructure #HealthData #CollaborativeResearch

The #SYNTHIA consortium is a robust collaboration of 32 esteemed partners, representing a diverse range of expertise from across Europe and beyond. Together, these expert organisations form a multidisciplinary community, leveraging their collective knowledge and resources to

Great news, our Partner TRAIN-ai.eu is presenting at the 66th annual meeting of ASH #ASH24 which is taking place right now! Saverio D'Amico, CEO of TRAIN, presents how AI-powered technology drives #innovation in #hematology. Part of the technology has

Another abstract by TRAIN-ai.eu presented at the ASH conference : “Generation of Multimodal Longitudinal Synthetic Data By Artificial Intelligence to Improve Personalized Medicine in #Hematology". Excellent fact -> This impressive work is highlighted in

#SYNTHIA PARTNER SPOTLIGHT: Sharmini Alagaratnam, is program director of the DNV Healthcare research programme, which has a strategic focus on assurance of AI for healthcare. She envisions a future where synthetic data drives innovation and trust in healthcare. Listen to

On behalf of all SYNTHIA Partners, we wish you a Happy New Year filled with new opportunities and achievements! May #2025 bring continued #innovations in #research that contribute to a healthier future for all. Here's to a successful and impactful year ahead!

#Syntheticdata, artificially generated to mimic real patient data, presents a solution to many of the challenges faced in #health #research today. These data allow #researchers to overcome the limitations of access to high-quality, #RWD real-world datasets and address growing

Attention, everyone at #SWAT4HCLS in Barcelona, Spain! Our partner, Núria Queralt Rosinach Núria Queralt Rosinach from Leiden University Medical Center (LUMC), will showcase the accepted SYNHTIA abstract as a poster, titled: Assessment of metadata descriptors of AI-ready datasets. Semantic Web

#SWAT4HCLS participants: Please connect with our partner, Núria Queralt Rosinach Núria Queralt Rosinach from Leiden University Medical Center (LUMC Leiden ) - find her poster, titled: Assessment of metadata descriptors of AI-ready datasets. #DataScience #syntheticdata

The WHO/Europe has published its European Health Report 2024, highlighting that 14 million people are living with dementia in the WHO European Region #EHR2024 alzheimer-europe.org/news/world-hea…

The SYNTHIA Consortium Supports #RareDiseaseDay 2025: Leverage synthetic data to advance personalized medicine in Multiple Myeloma and DLBC 💜 On #RareDiseaseDay2025 , we reaffirm our commitment to driving data-driven innovation for rare diseases. In SYNTHIA, we focus on 6 use

We talk a lot about synthetic data, but what is it? It mimics real health data while protecting privacy & fueling innovation. For rare diseases, where data is scarce, it helps researchers test & train solutions safely. Safe. Smart. Powerful. 👉Learn more: synthema.eu

How will you you support on Rare Disease Day this year? 💜🌍 Sharing a personal story, joining an event, or simply starting a conversation, every action is a step closer to equity for the 300 million people living with rare diseases. Find out more: rarediseaseday.org

We had the great fortune of working with Manuel de la Guia de la Guía Solaz, Scientific Officer at the Innovative Health Initiative. Watch his video. With support from the European Commission and industry leaders, the funding of IHI enables SYNTHIA to pioneer advancements in #SyntheticData and

SYNTHIA is proud to be part of the Health Data Summit 2025, a leading event on health data innovation - 19 & 20 March 2025, Brussels. The summit is organized by SYNTHIA partner i~HD. SYNTHIA partner Ahmed Youssef Ali, from Johnson Medical Innovations Johnson & Johnson, will be

We’re thrilled to share that SYNTHIA partner Ahmed Youssef Ali, key expert from Johnson & Johnson Medical Innovations (Johnson & Johnson), is presenting at the #HealthData Summit 2025 organized by i~HD. 📢 Session Spotlight: Data Quality in the Era of Synthetic Data - day 2 -

SYNTHIA Public Consultation: Your perspective matters! We are mapping the future of #syntheticdata in #healthcare — and we need your input -> Help us shape solutions that are aligned with real-world healthcare needs and share what content and features you value most in Europe’s

Our partner Gates Ventures represents SYNTHIA at the AD/PD - Advances in Science & Therapy AD/PD™ 2025 International Conference on #Alzheimers and Parkinson’s Diseases and related neurological disorders (April 1 - 5, 2025 | Vienna, Austria). Check the Alzheimer's Disease Data Initiative Alzheimer's Disease Data Initiative #ADPD2025

SYNTHIA: Leverage synthetic data to propel personalized medicine to new heights. SYNTHIA unites SDG developers, FAIR data experts, clinical researchers, developers of therapies and data-based tools, legal experts, socio-economic analysts, regulatory, policy advocacy, and

Can synthetic data revolutionize how we understand and treat complex blood cancers? We are excited to launch the SYNTHIA Insight series, designed to spotlight the science, people, and progress behind the SYNTHIA project. In our first edition, we speak with SYNTHIA Partner